Aimovig is the first FDA-approved treatment that blocks the CGRP receptor to help prevent migraine.

Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.

Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.